{
 "as_of": "2026-11-06",
 "cmr": "ch-cm-kg/BX/1CG",
 "fence": "The page is the record's research on the issuer — no analyst, no rating, no view.",
 "markdown": "The page is the record's research on the issuer — no analyst, no rating, no view.\n\n# CRISPR Therapeutics AG (BX Swiss: 1CG) — research page\n\nAs of 2026-11-06 · ch-cm-kg · record version 1\n\n## Identity and listing\n\nCRISPR Therapeutics AG is listed on BX Swiss under ticker 1CG, ISIN CH0334081137, LEI 506700O6IRRIQLT3W370. Its security type is Corporate. Segment and sector are not on the record. Jurisdiction is Switzerland, a Zefix-registered corporation. Status is listed, not halted.\n\n## The disclosure read\n\nThe record holds 22 filings across 19 filing days in the window 2025-11-06 to 2026-11-06, of which 20 are newswire releases and 2 are register mutations. The median gap between filing days is 17.0 days. The latest filing is dated 2026-11-04, a newswire release, 2 days before the record date of 2026-11-06. On BX Swiss the median cadence gap is 43.2 days across 19 issuers, the median filing count is 6, and the median latency is 9 days. Sector peer figures for CH are not on the record.\n\n## Auditor\n\nThe auditor and its location are not on the record. The record carries only the annual report link, which is a source link and not a read. Auditor changes are not on the record.\n\n## Events and halts\n\nListing, delisting, name change, domicile change and segment move are not on the record, as the register has no lifecycle type map yet. The halt flag shows listed, not halted.\n\n## Orderability\n\nThe signal code ACM-200 is determinable for each of the three client categories: Privatkundinnen und -kunden, professionelle Kunden and institutionelle Kunden. The rule version is acm-68000/ch/finsa-product-duties/r1, with the chapter as of 2026-11-04.\n\n## Coverage\n\nNo research houses were found on the issuer's investor-relations pages read. The count is 0.\n\n## Open research\n\nNo openly published research notes were found on the record. The count is 0.\n\n## Licensed\n\nLicensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.\n\n## As-of depth\n\nThe vintage is not sealed for this market. No sealed years are held for this issuer, and no earliest sealed date or live record start date is on the record.\n\n## Sources\n\n7 source pages are named on this page; every value above carries its own source page and read date in the numbers.\n\n- https://www.bxswiss.com/instruments/CH0334081137 (identity.exchange)\n- https://www.zefix.ch/en/search/entity/list?name=CRISPR%20Therapeutics%20AG (identity.jurisdiction)\n- https://mapping.gleif.org/api/v2/isin-lei/latest/download (identity.lei)\n- https://mcp.ch-cm-kg.ai/events/BX/1CG (the disclosure lines)\n- https://www.ser-ag.com/sheldon/official_notices/v2/find.json ; https://www.bxswiss.com/suspensions (the halt flag)\n- https://mcp.ch-cm-kg.ai/book/aio.json (the orderability chapter)\n- https://mcp.ch-cm-kg.ai/record/BX/1CG (the record)\n",
 "market": "CH",
 "node": "ch-cm-kg",
 "numbers": {
  "as_of_depth": {
   "issuer_years_sealed": [],
   "live_record_began": null,
   "node_history_from": null,
   "node_years_sealed": [],
   "note": "the CH vintage is not sealed; the record is the live record as of 2026-11-06",
   "record_version": 1,
   "sealed": false
  },
  "auditor": {
   "auditor": {
    "market": "CH",
    "reason": "Width 0 records the annual report link only (ORDER-015: source link, not a read)",
    "state": "not_on_record"
   },
   "auditor_firm_id": {
    "market": "CH",
    "state": "not_on_record"
   },
   "auditor_location": {
    "market": "CH",
    "state": "not_on_record"
   },
   "changes": {
    "market": "CH",
    "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)",
    "state": "not_on_record"
   }
  },
  "cmr": "ch-cm-kg/BX/1CG",
  "coverage": {
   "count": 0,
   "houses": [],
   "pages_checked": [],
   "read_by": "Perplexity sonar (search) · page read by this rail",
   "read_date": "2026-11-12",
   "since": null,
   "state": "none_found"
  },
  "disclosure": {
   "against": {
    "exchange": {
     "issuers": 19,
     "median_cadence_gap_days": 43.2,
     "median_filings": 6,
     "median_latency_days": 9,
     "name": "BX Swiss"
    },
    "sector": {
     "market": "CH",
     "state": "not_on_record"
    }
   },
   "by_type": {
    "newswire_release": 20,
    "register_mutation": 2
   },
   "cadence_median_gap_days": 17,
   "filing_days": 19,
   "filings": 22,
   "latency_days": 2,
   "latest": [
    {
     "category": null,
     "date": "2026-11-04",
     "source": "https://www.globenewswire.com/news-release/2026/11/04/3395391/0/en/crispr-therapeutics-to-present-clinical-data-from-zugo-cel-in-large-b-cell-lymphoma-at-the-68th-american-society-of-hematology-ash-annual-meeting-and-exposition.html",
     "title": "CRISPR Therapeutics to Present Clinical Data from Zugo-cel",
     "type": "newswire_release"
    },
    {
     "category": null,
     "date": "2026-11-02",
     "source": "https://www.globenewswire.com/news-release/2026/11/02/3393703/0/en/crispr-therapeutics-provides-business-update-and-reports-third-quarter-2026-financial-results.html",
     "title": "CRISPR Therapeutics Provides Business Update and Reports",
     "type": "newswire_release"
    },
    {
     "category": null,
     "date": "2026-11-02",
     "source": "https://www.globenewswire.com/news-release/2026/11/02/3393099/0/en/crispr-therapeutics-announces-the-appointment-of-siva-sakhamuri-ph-d-as-chief-technical-officer.html",
     "title": "CRISPR Therapeutics Announces the Appointment of Siva",
     "type": "newswire_release"
    },
    {
     "category": null,
     "date": "2026-10-08",
     "source": "https://www.globenewswire.com/news-release/2026/10/08/3377269/0/en/crispr-therapeutics-to-present-late-breaking-data-at-the-american-heart-association-aha-scientific-sessions-2026.html",
     "title": "CRISPR Therapeutics to Present Late-Breaking Data at the",
     "type": "newswire_release"
    },
    {
     "category": null,
     "date": "2026-10-02",
     "source": "https://www.globenewswire.com/news-release/2026/10/02/3373871/0/en/crispr-therapeutics-to-present-clinical-data-on-zugocabtagene-geleucel-zugo-cel-in-autoimmune-disease-at-the-american-college-of-rheumatology-acr-convergence-2026.html",
     "title": "CRISPR Therapeutics to Present Clinical Data on",
     "type": "newswire_release"
    }
   ],
   "latest_filing_date": "2026-11-04",
   "read": "the node's event lines (list_events_since), as get_filings serves them",
   "source": "https://mcp.ch-cm-kg.ai/events/BX/1CG",
   "window": {
    "from": "2025-11-06",
    "to": "2026-11-06"
   }
  },
  "identity": {
   "exchange": {
    "read_by": "BX Swiss instruments list (exchange list)",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://www.bxswiss.com/instruments/CH0334081137",
    "state": "sourced",
    "value": "BX Swiss"
   },
   "isin": {
    "read_by": "BX Swiss instruments list (exchange list)",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://www.bxswiss.com/instruments/CH0334081137",
    "state": "confirmed",
    "value": "CH0334081137"
   },
   "jurisdiction": {
    "read_by": "Zefix federal commercial register index (zefix.ch public web API, name-exact + corporation legal form) (legal form)",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://www.zefix.ch/en/search/entity/list?name=CRISPR%20Therapeutics%20AG",
    "state": "sourced",
    "value": "Switzerland (Zefix-registered corporation)"
   },
   "lei": {
    "read_by": "GLEIF ISIN-to-LEI mapping file (daily), LEI by exact ISIN",
    "read_date": "2026-11-09",
    "read_date_basis": "the field",
    "source": "https://mapping.gleif.org/api/v2/isin-lei/latest/download (ISIN CH0334081137)",
    "state": "sourced",
    "value": "506700O6IRRIQLT3W370"
   },
   "name": {
    "read_by": "BX Swiss instruments list (exchange list)",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://www.bxswiss.com/instruments/CH0334081137",
    "state": "sourced",
    "value": "CRISPR Therapeutics AG"
   },
   "sector": {
    "market": "CH",
    "reason": "the SIX feed returns an empty ICB industry for this line",
    "state": "not_on_record"
   },
   "security_type": {
    "read_by": "BX Swiss instruments list (exchange list)",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://www.bxswiss.com/instruments/CH0334081137",
    "state": "sourced",
    "value": "Corporate"
   },
   "segment": {
    "market": "CH",
    "state": "not_on_record"
   },
   "ticker": {
    "read_by": "BX Swiss instruments list (exchange list)",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://www.bxswiss.com/instruments/CH0334081137",
    "state": "sourced",
    "value": "1CG"
   },
   "website": {
    "market": "CH",
    "state": "not_on_record"
   }
  },
  "licensed": {
   "columns": [
    "licensor",
    "entitlement",
    "title",
    "date",
    "source"
   ],
   "rows": [],
   "rule": "A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded."
  },
  "lifecycle": {
   "delisting": {
    "market": "CH",
    "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)",
    "state": "not_on_record"
   },
   "domicile_change": {
    "market": "CH",
    "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)",
    "state": "not_on_record"
   },
   "listing": {
    "market": "CH",
    "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)",
    "state": "not_on_record"
   },
   "name_change": {
    "market": "CH",
    "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)",
    "state": "not_on_record"
   },
   "segment_move": {
    "market": "CH",
    "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)",
    "state": "not_on_record"
   }
  },
  "market": "CH",
  "node": "ch-cm-kg",
  "numbers_hash": "sha256:8ec4a1273ed773e1b88c4e29594ec0df0417583596660ecc88c425608665e0a7",
  "open_research": {
   "read_date": "2026-11-12",
   "rows": [],
   "state": "none_found"
  },
  "orderability": {
   "chapter_as_of": "2026-11-04",
   "client_categories": [
    "Privatkundinnen und -kunden",
    "professionelle Kunden",
    "institutionelle Kunden"
   ],
   "outcomes": {
    "Privatkundinnen und -kunden": {
     "determinable": true,
     "signal": "ACM-200"
    },
    "institutionelle Kunden": {
     "determinable": true,
     "signal": "ACM-200"
    },
    "professionelle Kunden": {
     "determinable": true,
     "signal": "ACM-200"
    }
   },
   "read": {
    "basis": "one live read per instrument class, halt state and client category on this market; this issuer's group",
    "chapter": "https://mcp.ch-cm-kg.ai/book/aio.json",
    "door": "https://mcp.ch-cm-kg.ai/mcp",
    "tool": "get_orderability"
   },
   "rule_version": "acm-68000/ch/finsa-product-duties/r1",
   "section": "ch.aio.v8"
  },
  "record": {
   "as_of": "2026-11-06",
   "url": "https://mcp.ch-cm-kg.ai/record/BX/1CG",
   "version": 1
  },
  "schema": "research-numbers v0.1 (USR-01, 2026-11-11)",
  "status": {
   "read_date": "2026-11-09",
   "source": "https://www.ser-ag.com/sheldon/official_notices/v2/find.json ; https://www.bxswiss.com/suspensions",
   "value": "listed, not halted"
  }
 },
 "numbers_hash": "sha256:8ec4a1273ed773e1b88c4e29594ec0df0417583596660ecc88c425608665e0a7",
 "path": "/ch/BX/1CG",
 "schema": "research-page v0.1 (USR-02, 2026-11-11)",
 "sections": [
  {
   "id": "identity",
   "text": "CRISPR Therapeutics AG is listed on BX Swiss under ticker 1CG, ISIN CH0334081137, LEI 506700O6IRRIQLT3W370. Its security type is Corporate. Segment and sector are not on the record. Jurisdiction is Switzerland, a Zefix-registered corporation. Status is listed, not halted.",
   "title": "Identity and listing"
  },
  {
   "id": "disclosure",
   "text": "The record holds 22 filings across 19 filing days in the window 2025-11-06 to 2026-11-06, of which 20 are newswire releases and 2 are register mutations. The median gap between filing days is 17.0 days. The latest filing is dated 2026-11-04, a newswire release, 2 days before the record date of 2026-11-06. On BX Swiss the median cadence gap is 43.2 days across 19 issuers, the median filing count is 6, and the median latency is 9 days. Sector peer figures for CH are not on the record.",
   "title": "The disclosure read"
  },
  {
   "id": "auditor",
   "text": "The auditor and its location are not on the record. The record carries only the annual report link, which is a source link and not a read. Auditor changes are not on the record.",
   "title": "Auditor"
  },
  {
   "id": "events",
   "text": "Listing, delisting, name change, domicile change and segment move are not on the record, as the register has no lifecycle type map yet. The halt flag shows listed, not halted.",
   "title": "Events and halts"
  },
  {
   "id": "orderability",
   "text": "The signal code ACM-200 is determinable for each of the three client categories: Privatkundinnen und -kunden, professionelle Kunden and institutionelle Kunden. The rule version is acm-68000/ch/finsa-product-duties/r1, with the chapter as of 2026-11-04.",
   "title": "Orderability"
  },
  {
   "id": "coverage",
   "text": "No research houses were found on the issuer's investor-relations pages read. The count is 0.",
   "title": "Coverage"
  },
  {
   "id": "open_research",
   "text": "No openly published research notes were found on the record. The count is 0.",
   "title": "Open research"
  },
  {
   "id": "licensed",
   "text": "Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.",
   "title": "Licensed"
  },
  {
   "id": "depth",
   "text": "The vintage is not sealed for this market. No sealed years are held for this issuer, and no earliest sealed date or live record start date is on the record.",
   "title": "As-of depth"
  },
  {
   "id": "sources",
   "text": "7 source pages are named on this page; every value above carries its own source page and read date in the numbers.",
   "title": "Sources"
  }
 ],
 "sources": [
  {
   "for": "identity.exchange",
   "source": "https://www.bxswiss.com/instruments/CH0334081137"
  },
  {
   "for": "identity.jurisdiction",
   "source": "https://www.zefix.ch/en/search/entity/list?name=CRISPR%20Therapeutics%20AG"
  },
  {
   "for": "identity.lei",
   "source": "https://mapping.gleif.org/api/v2/isin-lei/latest/download"
  },
  {
   "for": "the disclosure lines",
   "source": "https://mcp.ch-cm-kg.ai/events/BX/1CG"
  },
  {
   "for": "the halt flag",
   "source": "https://www.ser-ag.com/sheldon/official_notices/v2/find.json ; https://www.bxswiss.com/suspensions"
  },
  {
   "for": "the orderability chapter",
   "source": "https://mcp.ch-cm-kg.ai/book/aio.json"
  },
  {
   "for": "the record",
   "source": "https://mcp.ch-cm-kg.ai/record/BX/1CG"
  }
 ],
 "title": "CRISPR Therapeutics AG (1CG) — research page",
 "writer": {
  "by": "Claude through the platform account, Haiku class; one pass; checked against the numbers",
  "engine": "claude-haiku-5-5"
 }
}